A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

D’après les résultats d’une étude de phase III, l’utilisation de Keytruda (pembrolizumab), avant et après la chirurgie, a ...

Three children have died in the most recent outbreak of measles, to date. This article reviews the signs, symptoms, and treatment of measles, also known as rubeola.

Mammary gland fibroblasts are highly plastic and transition through distinct states during development and disease. A new ...

jetMESSENGER ® reagent considerably outstrips Lipofectamine ™ 2000 transfection reagent in T cells, reaching more elevated GFP expression while preserving cell integrity. In B cells, it shows superior ...

Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in ...

Les patients infectés par le VIH et qui restent en rémission malgré l'arrêt de leur traitement, pourtant théoriquement ...

Faire les rappels de vaccin dans le même bras que celui utilisé pour la première injection permettrait de développer des ...